Livzon Pharmaceutical Group Inc. (000513.SZ)
CNY 37.67
(-0.34%)
CNY 37.67
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.27 Billion | 12.62 Billion | 12.06 Billion | 10.52 Billion | 9.38 Billion | 8.86 Billion |
| Cost of Revenue | 4.92 Billion | 4.46 Billion | 4.25 Billion | 3.67 Billion | 3.39 Billion | 3.35 Billion |
| Gross Profit | 7.35 Billion | 8.16 Billion | 7.81 Billion | 6.84 Billion | 5.99 Billion | 5.5 Billion |
| Operating Expenses | 5.24 Billion | 5.93 Billion | 5.62 Billion | 4.53 Billion | 4.4 Billion | 4.39 Billion |
| Selling, General and Administrative Expenses | 4.17 Billion | 4.54 Billion | 4.12 Billion | 3.32 Billion | 3.35 Billion | 3.53 Billion |
| Research and Development Expenses | 1.33 Billion | 1.42 Billion | 1.14 Billion | 884.09 Million | 732.89 Million | 548.97 Million |
| Other Expenses | -360.58 Million | -36.88 Million | 351.71 Million | 318.2 Million | 320.44 Million | 142.43 Million |
| Cost and Expenses | 10.01 Billion | 10.39 Billion | 9.87 Billion | 8.2 Billion | 7.79 Billion | 7.75 Billion |
| Operating Income | 2.41 Billion | 2.35 Billion | 2.26 Billion | 2.5 Billion | 1.72 Billion | 1.27 Billion |
| Interest Expense | 106.88 Million | 97.54 Million | 83.99 Million | 25.31 Million | 7.25 Million | 16.77 Million |
| Income Tax Expense | 485.06 Million | 375.01 Million | 293.58 Million | 358.1 Million | 265.96 Million | 234.95 Million |
| Earnings before Tax | 2.38 Billion | 2.33 Billion | 2.24 Billion | 2.48 Billion | 1.72 Billion | 1.41 Billion |
| Net Income | 1.95 Billion | 1.9 Billion | 1.77 Billion | 1.71 Billion | 1.3 Billion | 1.08 Billion |
| Earnings Per Share Basic | 2.10 | 2.04 | 1.90 | 1.83 | 1.39 | 1.16 |
| Earnings Per Share Diluted | 2.10 | 2.04 | 1.90 | 1.83 | 1.39 | 1.16 |
| Weighted Average Shares Outstanding | 930.3 Million | 934.98 Million | 934.46 Million | 936.15 Million | 934.76 Million | 932.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 930.6 Million | 935.89 Million | 934.46 Million | 938.57 Million | 934.76 Million | 932.9 Million |
| Gross Margin | 0.60 | 0.65 | 0.65 | 0.65 | 0.64 | 0.62 |
| EBIT Margin | 0.27 | 0.26 | 0.24 | 0.28 | 0.23 | 0.21 |
| Profit Margin | 0.16 | 0.15 | 0.15 | 0.16 | 0.14 | 0.12 |
| EBITDA | 3.29 Billion | 3.03 Billion | 2.76 Billion | 2.95 Billion | 2.16 Billion | 1.82 Billion |
| Earnings Before Tax Margin | 0.20 | 0.19 | 0.19 | 0.24 | 0.18 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.79 Billion | 3 Billion | 3.24 Billion | 2.73 Billion | 12.27 Billion | 2.96 Billion |
| Cost of Revenue | 966.44 Million | 1.04 Billion | 1.14 Billion | 1.06 Billion | 4.92 Billion | 1.08 Billion |
| Gross Profit | 1.83 Billion | 1.95 Billion | 2.09 Billion | 1.66 Billion | 7.35 Billion | 1.88 Billion |
| Operating Expenses | 1.1 Billion | 1.22 Billion | 1.31 Billion | 1.4 Billion | 5.43 Billion | 1.41 Billion |
| Selling, General and Administrative Expenses | 1.4 Billion | 972.93 Million | 1.06 Billion | 919.24 Million | - | 1.24 Billion |
| Research and Development Expenses | 243.83 Million | 224.65 Million | 238.17 Million | 288.86 Million | - | 374.97 Million |
| Other Expenses | -548.01 Million | -25.04 Million | -4.44 Million | -201.75 Million | -291.02 Million | 2.87 Million |
| Cost and Expenses | 2.06 Billion | 2.26 Billion | 2.45 Billion | 2.47 Billion | 10.35 Billion | 2.49 Billion |
| Operating Income | 703.14 Million | 731.45 Million | 848.88 Million | 259.71 Million | 1.92 Billion | 558.8 Million |
| Interest Expense | 22.01 Million | 23.44 Million | 22.8 Million | 27.4 Million | 102.08 Million | 25.98 Million |
| Income Tax Expense | 103.26 Million | 125.33 Million | 128.36 Million | 139.27 Million | 485.06 Million | 96.49 Million |
| Earnings before Tax | 694.46 Million | 764.53 Million | 844.44 Million | 401.47 Million | 2.32 Billion | 546.74 Million |
| Net Income | 501.76 Million | 563.14 Million | 607.82 Million | 352.09 Million | 1.95 Billion | 466.98 Million |
| Earnings Per Share Basic | 0.55 | 0.61 | 0.65 | 0.38 | - | 0.50 |
| Earnings Per Share Diluted | 0.55 | 0.61 | 0.65 | 0.38 | - | 0.50 |
| Weighted Average Shares Outstanding | 918.75 Million | 924.17 Million | 935.11 Million | 923.93 Million | 929.12 Million | 931.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 918.75 Million | 924.17 Million | 935.11 Million | 923.93 Million | 930.6 Million | 931.41 Million |
| Gross Margin | 0.65 | 0.65 | 0.65 | 0.61 | 0.60 | 0.64 |
| EBIT Margin | 0.26 | 0.30 | 0.27 | 0.16 | - | 0.23 |
| Profit Margin | 0.18 | 0.19 | 0.19 | 0.13 | 0.16 | 0.16 |
| EBITDA | 716.47 Million | 901.36 Million | 875.13 Million | 436.3 Million | - | 671.28 Million |
| Earnings Before Tax Margin | 0.25 | 0.24 | 0.26 | 0.09 | 0.16 | 0.19 |
016450
LTI
5351
6928
ALPP
0H14